ORIGENIS
Origenis offers creative
services for drug design, synthesis, and characterisation driven by
its patented technology platform MOREsystem®.
Origenis creates novel target-focused and indication-optimised
pre-clinical compound families and the related IP to its
customers.
Origenis integrates essential Pharma concepts in a novel
process.
« Origenis offers
world-class scientific competence in combination with a proven
highly sophisticated system, which integrates many
different parameters resulting in the creation of new patentable
pharmaceutical compounds. Because of its design the system is
faster than the traditional way and yields more specific compounds.
»
